Pediatric rheumatology

Risk-updating nomogram for refractory systemic JIA in children: multicentre development and external validation

Rheumatology (Oxford)Published Prognostic model development and external validation study

Authors' conclusion

A nomogram-based approach integrating baseline disease activity with early response information enables risk updating after initial treatment and may support timely treatment individualization for rSJIA.

Study context

Population
Children with newly diagnosed sJIA, multicentre retrospective cohorttraining 55
Participants
128 children
Comparison
Update model vs baseline-only model
Outcome
Prespecified composite:
  • rSJIA outcome during follow-up
  • Model discrimination (AUC)
Methodological detailsretrospective cohort, multicentre, nomogram
  • Retrospective cohort
  • Multicentre
  • Nomogram

Performance

As reported in the abstract

Discrimination (AUC) for rSJIA
Test or modelAUC, internal testing (95% CI 0.803-1.000)AUC, external validation (95% CI 0.818-0.996)AUC, internal testing (95% CI 0.746-1.000)AUC, external validation (95% CI 0.679-0.926)
Update model0.9190.907— not stated in the abstract— not stated in the abstract
Baseline-only model— not stated in the abstract— not stated in the abstract0.8820.803

AUC, internal testing (95% CI 0.803-1.000)

Update model0.919
Baseline-only model— not stated in the abstract

AUC, external validation (95% CI 0.818-0.996)

Update model0.907
Baseline-only model— not stated in the abstract

AUC, internal testing (95% CI 0.746-1.000)

Update model— not stated in the abstract
Baseline-only model0.882

AUC, external validation (95% CI 0.679-0.926)

Update model— not stated in the abstract
Baseline-only model0.803

— not stated in the abstract

  • Update model vs sJADAS27 alone: DeLong P = 0.040 — update model outperformed
  • Update model vs sJADAS27 alone: DeLong P = 0.019 — update model outperformed

Further findings

Predictors of rSJIA in the update model

sJADAS27, OR per 1-point increase
1.34 (95% CI 1.06-1.69)
Rerash, OR
7.38 (95% CI 1.07-51.16)
tCID, OR per day (95% CI 0.99-1.08), non-significant
1.04

Original publication

Risk-updating nomogram for refractory systemic JIA in children: multicentre development and external validation. Rheumatology (Oxford). Published 23 May 2026. doi:10.1093/rheumatology/keag272

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.